The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Liu, Frank Xiaoqing ^a   Treharne, Catrin ^b   Culleton, Bruce ^a   Crowe, Lydia ^b   Arici, Murat ^c  

^a Baxter HealtCorporation   (United States)

^b Decision Resources Group   (United Kingdom)

^c Baxter International UK Compton ^*  (United Kingdom)

Author keywords

Budget impact analysis; End stage renal disease; High dose haemodialysis; Home haemodialysis; In centre haemodialysis; Peritoneal dialysis

Indexed keywords

ADULT; ARTICLE; BUDGET; COMPARATIVE STUDY; CONTROLLED STUDY; COST CONTROL; FINANCIAL MANAGEMENT; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOME DIALYSIS; HUMAN; IN CENTRE HEMODIALYSIS; NATIONAL HEALTH SERVICE; OUTCOME ASSESSMENT; PATIENT CARE; PERITONEAL DIALYSIS; POPULATION; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; TREATMENT DURATION; COST; ECONOMICS; EPIDEMIOLOGY; HOME CARE; HOSPITALIZATION; KIDNEY FAILURE, CHRONIC; MEDICAL FEE; MORTALITY; PATIENT TRANSPORT; PROBABILITY; PROCEDURES; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM; UTILIZATION;

BUDGETS; COST SAVINGS; COSTS AND COST ANALYSIS; ENGLAND; FEE-FOR-SERVICE PLANS; HEMODIALYSIS, HOME; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MARKOV CHAINS; NATIONAL HEALTH PROGRAMS; PERITONEAL DIALYSIS; TRANSPORTATION OF PATIENTS;

EID: 84908002071     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-161     Document Type: Article

References (74)

1. CKD stages. The Renal Association, Available from: http://www.renal.org/information-resources/the-uk-eckd-guide/ckd-stages#sthash.Oyn3Whuo.dpbs (Accessed July 2014)
2. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Mowatt G, Vale L, Perez J, Wyness L, Fraser C, MacLeod A, Daly C, Stearns S, Health Technol Assess 2003 Available from: http://www.journalslibrary.nihr.ac.uk/hta/volume-7/issue-2 (Accessed 16 September 2013)
3. UK Renal Registry 16th Annual Report: chapter 2 UK RRT prevalence in 2012: National and Centre-specific Analyses. Shaw C, 2013 Available from: http://www.renalreg.com/Report-Area/Report%202013/02-Chap-02.pdf. (Accessed January 2014)
4. UK Renal Registry 16th Annual Report: chapter 1 UK renal replacement therapy incidence in 2012: National and Centre-specific Analyses. Gilg J, 2013 Available from: http://www.renalreg.com/Report-Area/Report%202013/01-Chap-01.pdf (Accessed January 2014)
5. Peritoneal dialysis (Clinical guidelines, CG125). peritoneal dialysis in the treatment of stage 5 chronic kidney disease. National Institute for Health and Clinical Excellence (NICE), Available from http://www.nice.org.uk/guidance/CG125 (Accessed July 2014)
6. Kidney disease: peritoneal dialysis. costing report. Implementing NICE guidance. National Institute for Health and Clinical Excellence (NICE), 2011 Available from: http://www.nice.org.uk/guidance/cg125/resources/cg125-peritoneal-dialysis-costing-report2 (Accessed July 2014)
7. Technology Appraisal Guidance No. 48. guidance on home compared with hospital haemodialysis for patients with end-stage renal failure. National Institute for Clinical Excellence, 2002 Available from: http://www.nice.org.uk/guidance/TA48 (Accessed July 2014)
8. Gaining efficiencies: resources and demand for dialysis around the globe. Neil N, Walker DR, Sesso R, Blackburn JC, Tschosik EA, Sciaraffia V, Garcia-Contreras F, Capsa D, Bhattacharyya SK, Value Health 2009 12 1 73 79 10.1111/j.1524-4733.2008.00414.x 18680485
9. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Johansen KL, Zhang R, Huang Y, Chen SC, Blagg CR, Goldfarb-Rumyantzev AS, Hoy CD, Lockridge RS Jr, Miller BW, Eggers PW, Kutner NG, Kidney Int 2009 76 9 984 990 10.1038/ki.2009.291 19692997
10. Long interdialytic interval and mortality among patients receiving hemodialysis. Foley RN, Gilbertson DT, Murray T, Collins AJ, N Engl J Med 2011 365 12 1099 1107 10.1056/NEJMoa1103313 21992122
11. Comparison of survival between short-daily hemodialysis and conventional hemodialysis using the standardized mortality ratio. Blagg CR, Kjellstrand CM, Ting GO, Young BA, Hemodial Int 2006 10 4 371 374 10.1111/j.1542-4758.2006.00132.x 17014514
12. Home hemodialysis and mortality risk in Australian and New Zealand populations. Marshall MR, Hawley CM, Kerr PG, Polkinghorne KR, Marshall RJ, Agar JW, McDonald SP, Am J Kidney Dis 2011 58 5 782 793 10.1053/j.ajkd.2011.04.027 21816526
13. Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. Nesrallah GE, Lindsay RM, Cuerden MS, Garg AX, Port F, Austin PC, Moist LM, Pierratos A, Chan CT, Zimmerman D, Lockridge RS, Couchoud C, Chazot C, Ofsthun N, Levin A, Copland M, Courtney M, Steele A, McFarlane PA, Geary DF, Pauly RP, Komenda P, Suri RS, J Am Soc Nephrol 2012 23 4 696 705 10.1681/ASN.2011070676 22362910
14. In-center hemodialysis six times per week versus three times per week. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS, N Engl J Med 2010 363 24 2287 2300 21091062
15. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ, JAMA 2007 298 11 1291 1299 10.1001/jama.298.11.1291 17878421
16. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, et al. Kidney Int 2011 80 10 1080 1091 10.1038/ki.2011.213 21775973
17. Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Kooistra MP, Vos J, Koomans HA, Vos PF, Nephrol Dial Transplant 1998 13 11 2853 2860 10.1093/ndt/13.11.2853 9829490
18. Improved nutrition after conversion to nocturnal home hemodialysis. Sikkes ME, Kooistra MP, Weijs PJ, J Ren Nutr 2009 19 6 494 499 10.1053/j.jrn.2009.05.006 19616453
19. Estimating the financial cost of chronic kidney disease to the NHS in England. Kerr M, Bray B, Medcalf J, O'Donoghue DJ, Matthews B, Nephrol Dial Transplant 2012 27 Suppl 3 ii73 iii80 22815543
20. Burden of chronic kidney disease: an international perspective. Ayodele OE, Alebiosu CO, Adv Chronic Kidney Dis 2010 17 3 215 224 10.1053/j.ackd.2010.02.001 20439090
21. High dose in-centre haemodialysis and conventional in-centre haemodialysis: a head-to-head cost-effectiveness analysis. ASN Poster No. FR-PO341. Liu F, Treharne C, Lees L, Arici M, Culleton B, 2013
22. High dose home haemodialysis and conventional in-centre haemodialysis: a cost utility analysis. ASN Poster No. FR-PO340. Liu F, Treharne C, Culleton B, Arici M, Lees L, 2013
23. The cost of renal dialysis in a UK setting-a multicentre study. Baboolal K, McEwan P, Sondhi S, Spiewanowski P, Wechowski J, Wilson K, Nephrol Dial Transplant 2008 23 6 1982 1989 10.1093/ndt/gfm870 18174268
24. Dialysis for end-stage renal disease. determining a cost-effective approach. Kirby L, Vale L, Int J Technol Assess Health Care 2001 17 2 181 189 10.1017/S0266462300105045 11446130
25. Peritoneal dialysis in the treatment of stage 5 chronic kidney disease. NICE clinical guideline 125 (CG125). National Institute for Health and Clinical Excellence (NICE), 2011 Available from: http://www.nice.org.uk/guidance/cg125/resources/cg125-peritoneal-dialysis-full-guideline3 (Accessed January 2014)
26. Economic report home haemodialysis. CEP10063. NHS Purchasing and Supply Agency, 2010 Available from: http://nhscep.useconnect.co.uk/CEPProducts/Catalogue.aspx?ReportType=Economic +report (Accessed October 2014)
27. Clinical practice guidelines-haemodialysis. The Renal Association, Available from: http://www.renal.org/guidelines/modules/haemodialysis#sthash.un8BVrDp.dpbs (Accessed January 2014)
28. ERA-EDTA Registry Annual Report 2009. European Renal Association (ERA) and European Dialysis and Transplant Association (EDTA), Available from http://www.era-edta-reg.org/files/annualreports/pdf/AnnRep2009.pdf (Accessed March 2013)
29. ERA-EDTA Registry Annual Report 2011. European Renal Association (ERA) and European Dialysis and Transplant Association (EDTA), Available from: http://www.era-edta-reg.org/files/annualreports/pdf/AnnRep2011.pdf (Accessed November 2013)
30. Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Marshall MR, Byrne BG, Kerr PG, McDonald SP, Kidney Int 2006 69 7 1229 1236 10.1038/sj.ki.5000188 16609687
31. The International Quotidian Dialysis Registry: annual report 2008. Nesrallah GE, Suri RS, Moist LM, Ofsthun NJ, Hakim R, McDonald SP, Marshall MR, Carter ST, Lindsay RM, Hemodial Int 2008 12 3 281 289 10.1111/j.1542-4758.2008.00268.x 18638080
32. Activity report 2012/13. transplant activity in the UK. NHS Blood and Transplant, http://www.organdonation.nhs.uk/statistics/transplant-activity-report/current-activity-reports/ukt/activity-report-2012-13.pdf (Accessed December 2013)
33. Hospital utilization among chronic dialysis patients. Arora P, Kausz AT, Obrador GT, Ruthazer R, Khan S, Jenuleson CS, Meyer KB, Pereira BJ, J Am Soc Nephrol 2000 11 4 740 746 10752533
34. Association of dialysis modality with risk for infection-related hospitalization: a propensity score-matched cohort analysis. Lafrance JP, Rahme E, Iqbal S, Elftouh N, Vallee M, Laurin LP, Ouimet D, Clin J Am Soc Nephrol 2012 7 10 1598 1605 10.2215/CJN.00440112 22904124
35. USRDS 2012 Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States. U S Renal Data System, Available from http://www.usrds.org/atlas.aspx (Accessed March 2013)
36. UK Renal Registry 13th Annual Report (December 2010): Chapter 9: haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2009: national and centre-specific analyses. Gilg J, Webb L, Feest T, Fogarty D, Nephron Clin Pract 2011 119 Suppl 2 149 c177 21894032
37. UK Renal Registry 13th Annual Report (December 2010): chapter 2: UK RRT prevalence in 2009: national and centre-specific analyses. Steenkamp R, Castledine C, Feest T, Fogarty D, Nephron Clin Pract 2011 119 Suppl 2 27 c52
38. The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA, Kidney Int 2006 69 5 798 805 10.1038/sj.ki.5000059 16407887
39. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, Bannister KM, Wiggins KJ, Am J Kidney Dis 2009 53 2 290 297 10.1053/j.ajkd.2008.06.032 18805609
40. Cost-effectiveness analysis of renal replacement therapy in Austria. Haller M, Gutjahr G, Kramar R, Harnoncourt F, Oberbauer R, Nephrol Dial Transplant 2011 26 9 2988 2995 10.1093/ndt/gfq780 21310740
41. Payment by results 2013-2014. Department of Health, Available from: https://www.gov.uk/government/collections/payment-by-results-2013-14 (Accessed January 2014)
42. NHS Reference costs 2011-12. Department of Health, Available from: http://www.dh.gov.uk/health/2012/11/2011-12-reference-costs/ (Accessed January 2014)
43. British Medical Association, British National Formulary (BNF), No. 67 London: British Medical Association and the Royal Pharmaceutical Society of Great Britain 2014
44. NHS Reference costs 2009-10. Department of Health, Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-123459 (Accessed January 2014)
45. National kidney care audit. patient transport survey 2010. The NHS Information Centre, Available from: http://www.hqip.org.uk/assets/NCAPOP-Library/NHS-Patient-Transport-2010Final-Web-Version.pdf (Accessed January 2014)
46. Z1-Recovery of benefits and or lump sum payments and NHS charges: procedures for liaison with the Compensation Recovery Unit. Department for Work and Pensions, 2013 Available from: https://www.gov.uk/government/publications/recovery-of-benefits-and-or-lump-sum-payments-and-nhs-charges-technical-guidance (Accessed December 2013)
47. Developing robust reference costs for kidney transplantation in adults. NHS Kidney Care, 2011 Available from: http://webarchive.nationalarchives.gov.uk/20130504185629/http://kidneycare.nhs.uk/resources/?dispFolder=458# (Accessed October 2014)
48. NHS Reference costs 2012-13. Department of Health, Available from: https://www.gov.uk/government/publications/nhs-reference-costs-2012-to-2013 (Accessed February 2014)
49. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, Orlewska E, Penna P, Rodriguez Barrios JM, Shau WY, Value Health 2014 17 1 5 14 10.1016/j.jval.2013.08.2291 24438712
50. Frequently asked questions. Payment by Results (PbR)-renal dialysis. NHS Kidney Care, 2011 Available from http://webarchive.nationalarchives.gov.uk/20130504185629/http://kidneycare.nhs.uk/resources/?dispFolder=503# (Accessed January 2014)
51. UK Renal Registry 15th Annual Report (December 2012): chapter 6: haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2011: national and centre-specific analyses. Rao A, Gilg J, Williams A, Available from: http://www.renalreg.com/Report-Area/Report%202012/Chapter-6.pdf (Accessed January 2014)
52. National Tariff 2010-2011. Department of Health, Available from: http://data.gov.uk/dataset/payment-by-results-2010-11-national-tariff-information (Accessed October 2014)
53. UK Renal Registry. the ninth annual report. december 2006. chapter 3: new adult patients starting renal replacement therapy in the UK in 2005. Farrington K, Rao R, Gilg J, Ansell D, T F, Available from: http://www.renalreg.com/Report-Area/Report%202006/Chapter03.pdf (Accessed January 2014)
54. UK Renal Registry Report 2007. chapter 3: new adult patients starting renal replacement therapy in the UK in 2006. Farrington K, Udayaraj U, Gilg J, T F, Feehally J, Available from: http://www.renalreg.com/AllReports/Report2007.pdf (Accessed January 2014)
55. UK Renal Registry. the eleventh annual report. december 2008. chapter 3. ESRD incident rates in 2007 in the UK: national and centre-specific analyses. Farrington K, Udayaraj U, Gilg J, Feehally J, Available from: http://www.renalreg.com/Report-Area/Report%202008/Chapter03.pdf (Accessed January 2014)
56. UK Renal Registry 12th Annual Report (December 2009): chapter 3: UK ESRD incident rates in 2008: national and centre-specific analyses. Byrne C, Ford D, Gilg J, Ansell D, Feehally J, Nephron Clin Pract 2010 115 Suppl 1 9 c39 20413958
57. A home dialysis manifesto. a report of the findings of the 2013 home dialysis summit. National Kidney Foundation, Available from: http://www.kidney.org.uk/documentlibrary/Home-Dialysis-Report.pdf (Accessed July 2013)
58. UK Renal Registry 16th Annual Report: chapter 10 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2012: national and centre-specific analyses. Rao A, Gilg J, Williams A, Available from: http://www.renalreg.com/Report-Area/Report%202013/10-Chap-10.pdf (Accessed May 2014)
59. Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy. David S, Kumpers P, Eisenbach GM, Haller H, Kielstein JT, Nephrol Dial Transplant 2009 24 7 2232 2240 10.1093/ndt/gfp029 19208770
60. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A, Kidney Int 2002 61 6 2235 2239 10.1046/j.1523-1755.2002.00362.x 12028465
61. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Liem YS, Bosch JL, Hunink MG, Value Health 2008 11 4 733 741 10.1111/j.1524-4733.2007.00308.x 18194399
62. Outcome of home haemodialysis patients: a case-cohort study. Saner E, Nitsch D, Descoeudres C, Frey FJ, Uehlinger DE, Nephrol Dial Transplant 2005 20 3 604 610 10.1093/ndt/gfh674 15665030
63. Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years. Kjellstrand CM, Buoncristiani U, Ting G, Traeger J, Piccoli GB, Sibai-Galland R, Young BA, Blagg CR, Nephrol Dial Transplant 2008 23 10 3283 3289 10.1093/ndt/gfn210 18458034
64. Survival with short-daily hemodialysis: association of time, site, and dose of dialysis. Kjellstrand C, Buoncristiani U, Ting G, Traeger J, Piccoli GB, Sibai-Galland R, Young BA, Blagg CR, Hemodial Int 2010 14 4 464 470 10.1111/j.1542-4758.2010.00475.x 20854330
65. Chapter 2 UK RRT prevalence in 2010: national and centre-specific analyses. Castledine C, Casula A, Fogarty D, Nephron Clin Pract 2012 120 Suppl 1 29 c54 22964573
66. Making the NHS more efficient and less bureaucratic (March 2013). Department of Health, Available from: https://www.gov.uk/government/policies/making-the-nhs-more-efficient-and-less-bureaucratic (Accessed July 2013)
67. Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis. Golper TA, Saxena AB, Piraino B, Teitelbaum I, Burkart J, Finkelstein FO, Abu-Alfa A, Am J Kidney Dis 2011 58 6 879 885 10.1053/j.ajkd.2011.06.028 21903316
68. The role of peritoneal dialysis in modern renal replacement therapy. Goodlad C, Brown E, Postgrad Med J 2013 89 1056 584 590 10.1136/postgradmedj-2012-131406 23908406
69. What influences patient choice of treatment modality at the pre-dialysis stage? Chanouzas D, Ng KP, Fallouh B, Baharani J, Nephrol Dial Transplant 2012 27 4 1542 1547 10.1093/ndt/gfr452 21865216
70. Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives. Juergensen E, Wuerth D, Finkelstein SH, Juergensen PH, Bekui A, Finkelstein FO, Clin J Am Soc Nephrol 2006 1 6 1191 1196 10.2215/CJN.01220406 17699347
71. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR, JAMA 2004 291 6 697 703 10.1001/jama.291.6.697 14871912
72. Why patients with ESRD do not select self-care dialysis as a treatment option. McLaughlin K, Manns B, Mortis G, Hons R, Taub K, Am J Kidney Dis 2003 41 2 380 385 10.1053/ajkd.2003.50047 12552500
73. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW, Am J Kidney Dis 2004 43 5 891 899 10.1053/j.ajkd.2003.12.051 15112180
74. Cost-effectiveness of frequent in-center hemodialysis. Lee CP, Zenios SA, Chertow GM, J Am Soc Nephrol 2008 19 9 1792 1797 10.1681/ASN.2008010001 18614773